Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-3-2
pubmed:abstractText
We previously described that V3 loop derived from the HTLV-III BH10 clone V3-BH10 markedly suppressed IL-2-driven T cell proliferation and produced G1 arrest of the cells. Here, we tested the effect of V3-BH10 on the molecules that are involved in transition from the G1 to S phase of the cell cycle. The effect of V3-BH10 on the IL-2-induced expression of G1 cyclins, Cdk inhibitors, and phosphorylation of retinoblastoma protein (pRb) was tested by immunoblotting, using the IL-2-dependent CD4-positive cell line Kit 225. Furthermore, IL-2-dependent kinase activity of the cyclin E-Cdk2 complex was investigated with histone H1 as a substrate. V3-BH10 reduced the IL-2-dependent expression of cyclin E, but not that of cyclin D and Cdk inhibitors such as p21 and p27. As the result of reduction of cyclin E, histone H1 kinase activity of the cyclin E-Cdk2 complex was markedly reduced even in the presence of rIL-2, followed by incomplete phosphorylation of pRb. The reduction in hyperphosphorylation of pRb by V3-BH10 led to G1 arrest of the cell cycle. Thus, V3-BH10 induced G1 arrest in IL-2-dependent cell cycle progression by reducing cyclin E expression, which may be one of the mechanisms underlying the dysfunction of T cells in HIV-1-infected people.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/CCND2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CCND3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CDC2-CDC28 Kinases, http://linkedlifedata.com/resource/pubmed/chemical/CDK2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D1, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D2, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D3, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin E, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Cyclins, http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp120, http://linkedlifedata.com/resource/pubmed/chemical/HIV envelope protein gp120 (305-321), http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/histone H1 kinase
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0889-2229
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:9453249-Blotting, Western, pubmed-meshheading:9453249-CDC2-CDC28 Kinases, pubmed-meshheading:9453249-Cells, Cultured, pubmed-meshheading:9453249-Cyclin D1, pubmed-meshheading:9453249-Cyclin D2, pubmed-meshheading:9453249-Cyclin D3, pubmed-meshheading:9453249-Cyclin E, pubmed-meshheading:9453249-Cyclin-Dependent Kinase 2, pubmed-meshheading:9453249-Cyclin-Dependent Kinases, pubmed-meshheading:9453249-Cyclins, pubmed-meshheading:9453249-G1 Phase, pubmed-meshheading:9453249-HIV Envelope Protein gp120, pubmed-meshheading:9453249-HIV-1, pubmed-meshheading:9453249-Humans, pubmed-meshheading:9453249-Interleukin-2, pubmed-meshheading:9453249-Peptide Fragments, pubmed-meshheading:9453249-Phosphorylation, pubmed-meshheading:9453249-Protein Kinases, pubmed-meshheading:9453249-Protein-Serine-Threonine Kinases, pubmed-meshheading:9453249-Recombinant Proteins, pubmed-meshheading:9453249-S Phase, pubmed-meshheading:9453249-T-Lymphocytes
pubmed:year
1998
pubmed:articleTitle
V3 loop of human immunodeficiency virus type 1 reduces cyclin E expression and induces G1 arrest in interleukin 2-dependent T cells.
pubmed:affiliation
Research Center for Immunodeficiency Virus, Institute for Virus Research, Kyoto University, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't